about
IFITM proteins restrict viral membrane hemifusion.The IFITM proteins inhibit HIV-1 infectionCPT-cGMP Is A New Ligand of Epithelial Sodium ChannelsShort-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1Dual HIV-1 infection associated with rapid disease progressionInduction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a TriggerThe N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization.The C-terminal sequence of IFITM1 regulates its anti-HIV-1 activityIdentification of an endocytic signal essential for the antiviral action of IFITM3.TIM-family proteins inhibit HIV-1 release.Membrane fusion and cell entry of XMRV are pH-independent and modulated by the envelope glycoprotein's cytoplasmic tailCorrelation of apical fluid-regulating channel proteins with lung function in human COPD lungsHIV-1 mutates to evade IFITM1 restriction.Human RON receptor tyrosine kinase induces complete epithelial-to-mesenchymal transition but causes cellular senescence.A sorting signal suppresses IFITM1 restriction of viral entry.Putative phosphatidylinositol 3-kinase (PI3K) binding motifs in ovine betaretrovirus Env proteins are not essential for rodent fibroblast transformation and PI3K/Akt activationCritical role of leucine-valine change in distinct low pH requirements for membrane fusion between two related retrovirus envelopes.Nonhuman Primate IFITM Proteins Are Potent Inhibitors of HIV and SIV.Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins.IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein.Jaagsiekte sheep retrovirus utilizes a pH-dependent endocytosis pathway for entry.Fusogenicity of Jaagsiekte sheep retrovirus envelope protein is dependent on low pH and is enhanced by cytoplasmic tail truncations.Cell-cell contact promotes Ebola virus GP-mediated infection.Oncogenic transformation by the jaagsiekte sheep retrovirus envelope protein.Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection.Removal of regulatory T cells prevents secondary chronic infection but increases the mortality of subsequent sub-acute infection in sepsis mice.Evidence against a role for jaagsiekte sheep retrovirus in human lung cancer.Transformation of madin-darby canine kidney epithelial cells by sheep retrovirus envelope proteins.Interferon-inducible LY6E Protein Promotes HIV-1 Infection.Exogenous expression of SAMHD1 inhibits proliferation and induces apoptosis in cutaneous T-cell lymphoma-derived HuT78 cells.Single residues in the surface subunits of oncogenic sheep retrovirus envelopes distinguish receptor-mediated triggering for fusion at low pH and infection.Selection for human immunodeficiency virus type 1 recombinants in a patient with rapid progression to AIDS.Jaagsiekte sheep retrovirus envelope efficiently pseudotypes human immunodeficiency virus type 1-based lentiviral vectors.The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.Genetic evaluation of suspected cases of transient HIV-1 infection of infants.HIV-1 Envelope Glycoprotein at the Interface of Host Restriction and Virus Evasion.New virus in China requires international control effortEmerging Role of LY6E in Virus-Host Interactions
P50
Q21558779-821CE5DE-9593-42A9-9EB9-AA475354DF8AQ24629626-0BC915A8-6C40-4F2E-AB2A-CF934014A079Q26750624-9B84AD03-00D8-48AC-A522-2F7CE582A4EEQ27683583-7FA93C9A-4657-4761-867C-B542DE70593BQ28247153-F013E4BC-8DD9-4B6E-9F2C-A82F52673FBEQ30361292-F99AB99C-0339-4C7C-B7D5-DF955CA4CC24Q30422163-2FB19A53-18CC-4C33-BA48-534FB8C214B3Q30973896-AD356067-EDF8-4BD5-8DA2-A5C0028038BEQ33784795-9D544EDA-17EE-46C5-B24B-5867CE69B0D3Q34144143-450FE5D7-D885-48EC-8123-D08100CC9C62Q34221609-B25F0254-2742-45B2-A206-023CAFBCFB0BQ34361842-8CE04F62-CCB2-4118-9BD0-657D122473CCQ34761788-7F875133-E58E-4B30-A729-E6C4186ED0E5Q34976789-2A061B70-2B40-41EA-A6E5-045A9E7512C5Q35080316-D8A862E3-C4FD-48AE-B435-E790D0D93B55Q35105337-619374B0-1656-4374-BD25-D3D8D34C3BEBQ35801854-0B7600F1-A01A-49DD-A9D5-05A4DC45C4ABQ36039523-3195F87A-5E78-466A-923F-783460E072C0Q36090006-B38A87F0-1CAC-4FA4-9D1F-555552BBA740Q36150469-A475628C-B866-4AFD-90E3-FAA43E352AD6Q36483877-74DB4D10-A52B-4069-BE71-904010D4492DQ36483892-64A1B0F9-0719-4D0D-92D4-7D54ED9310BBQ36553687-45923AB6-2890-48B2-B29F-CF170CD3896FQ36565761-8D419E7C-488B-4A3A-A84B-24F4566F16D8Q36898654-BB192EFF-41DA-4881-A7E4-6D2BECF3CA11Q36998138-6E76A989-885A-4B04-9FDC-43B1A616FB58Q37595738-1EDF451C-E23F-4039-86D7-B50BDC66BFAEQ37743964-C94E70C8-0386-4065-8C20-D4F2340AFD81Q38719032-16E2758F-2381-4A9F-AC23-64F83B26B87FQ38727148-09C003EC-D914-41C3-AE5D-A70BABDC1AABQ39454668-EAABF496-B092-4742-89D0-12C882EEFD78Q39685176-B2680FEC-6306-4129-A65B-2381CFF572F6Q40676771-4A535EF1-660A-4574-9B64-3B787A9EC043Q41984737-23E80D74-8AF2-4F96-A826-31293C38304FQ48037639-79112B1D-24CE-4987-A468-9D7D14E382D1Q64972531-0302F8EA-4449-4149-B535-3B340BD79749Q83601003-f40eb484-41b2-effb-7670-cbaabecf4a67Q91097897-219DC636-4059-4C2E-BE86-66ABBF359D89
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Shan-Lu Liu
@ast
Shan-Lu Liu
@en
Shan-Lu Liu
@es
Shan-Lu Liu
@nl
Shan-Lu Liu
@sl
type
label
Shan-Lu Liu
@ast
Shan-Lu Liu
@en
Shan-Lu Liu
@es
Shan-Lu Liu
@nl
Shan-Lu Liu
@sl
prefLabel
Shan-Lu Liu
@ast
Shan-Lu Liu
@en
Shan-Lu Liu
@es
Shan-Lu Liu
@nl
Shan-Lu Liu
@sl
P1053
L-5923-2016
P106
P1153
57192661133
7409461598
P31
P3829
P496
0000-0003-1620-3817
P5008
P569
2000-01-01T00:00:00Z